QQQ   307.55 (+0.52%)
AAPL   157.72 (+0.20%)
MSFT   271.27 (-0.35%)
META   200.36 (+1.29%)
GOOGL   104.11 (+2.86%)
AMZN   99.49 (+1.82%)
TSLA   194.75 (+6.28%)
NVDA   257.92 (-0.42%)
NIO   9.25 (+5.71%)
BABA   83.21 (+2.73%)
AMD   94.82 (-2.06%)
T   18.50 (+0.05%)
F   11.73 (+4.92%)
MU   58.04 (+0.69%)
CGC   1.98 (+6.45%)
GE   92.58 (+2.96%)
DIS   96.33 (+2.24%)
AMC   4.38 (+2.58%)
PFE   40.46 (-0.86%)
PYPL   75.38 (+2.96%)
NFLX   305.76 (+0.21%)
QQQ   307.55 (+0.52%)
AAPL   157.72 (+0.20%)
MSFT   271.27 (-0.35%)
META   200.36 (+1.29%)
GOOGL   104.11 (+2.86%)
AMZN   99.49 (+1.82%)
TSLA   194.75 (+6.28%)
NVDA   257.92 (-0.42%)
NIO   9.25 (+5.71%)
BABA   83.21 (+2.73%)
AMD   94.82 (-2.06%)
T   18.50 (+0.05%)
F   11.73 (+4.92%)
MU   58.04 (+0.69%)
CGC   1.98 (+6.45%)
GE   92.58 (+2.96%)
DIS   96.33 (+2.24%)
AMC   4.38 (+2.58%)
PFE   40.46 (-0.86%)
PYPL   75.38 (+2.96%)
NFLX   305.76 (+0.21%)
QQQ   307.55 (+0.52%)
AAPL   157.72 (+0.20%)
MSFT   271.27 (-0.35%)
META   200.36 (+1.29%)
GOOGL   104.11 (+2.86%)
AMZN   99.49 (+1.82%)
TSLA   194.75 (+6.28%)
NVDA   257.92 (-0.42%)
NIO   9.25 (+5.71%)
BABA   83.21 (+2.73%)
AMD   94.82 (-2.06%)
T   18.50 (+0.05%)
F   11.73 (+4.92%)
MU   58.04 (+0.69%)
CGC   1.98 (+6.45%)
GE   92.58 (+2.96%)
DIS   96.33 (+2.24%)
AMC   4.38 (+2.58%)
PFE   40.46 (-0.86%)
PYPL   75.38 (+2.96%)
NFLX   305.76 (+0.21%)
QQQ   307.55 (+0.52%)
AAPL   157.72 (+0.20%)
MSFT   271.27 (-0.35%)
META   200.36 (+1.29%)
GOOGL   104.11 (+2.86%)
AMZN   99.49 (+1.82%)
TSLA   194.75 (+6.28%)
NVDA   257.92 (-0.42%)
NIO   9.25 (+5.71%)
BABA   83.21 (+2.73%)
AMD   94.82 (-2.06%)
T   18.50 (+0.05%)
F   11.73 (+4.92%)
MU   58.04 (+0.69%)
CGC   1.98 (+6.45%)
GE   92.58 (+2.96%)
DIS   96.33 (+2.24%)
AMC   4.38 (+2.58%)
PFE   40.46 (-0.86%)
PYPL   75.38 (+2.96%)
NFLX   305.76 (+0.21%)
NASDAQ:CRSP

CRISPR Therapeutics - CRSP Insider Trading & Ownership

$44.31
-0.15 (-0.34%)
(As of 03/21/2023 12:46 PM ET)
Add
Compare
Today's Range
$43.41
▼
$44.72
50-Day Range
$43.22
▼
$56.12
52-Week Range
$38.94
▼
$86.95
Volume
519,189 shs
Average Volume
1.07 million shs
Market Capitalization
$3.48 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$74.59

CRISPR Therapeutics (NASDAQ:CRSP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$12.96 M

CRSP Insider Buying and Selling by Quarter

Get CRSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CRISPR Therapeutics Insider Trades History

Export to Excel
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/27/2023Samarth KulkarniCEOSell25,000$48.25$1,206,250.00375,988  
1/27/2023Samarth KulkarniCEOSell25,000$51.47$1,286,750.00369,111  
12/28/2022Samarth KulkarniCEOSell25,000$40.93$1,023,250.00369,111  
11/28/2022Samarth KulkarniCEOSell25,000$54.03$1,350,750.00290,279  
10/26/2022Samarth KulkarniCEOSell25,000$54.81$1,370,250.00290,279  
9/28/2022Samarth KulkarniCEOSell25,000$64.61$1,615,250.00290,279  
8/29/2022Samarth KulkarniCEOSell25,000$66.84$1,671,000.00290,279  
7/27/2022Samarth KulkarniCEOSell25,000$75.91$1,897,750.00290,279  
6/29/2022Samarth KulkarniCEOSell25,000$61.59$1,539,750.00290,279  
(Data available from 1/1/2013 forward)












CRSP Insider Trading Activity - Frequently Asked Questions

Who is on CRISPR Therapeutics's Insider Roster?

The list of insiders at CRISPR Therapeutics includes Bradley J Phd Bolzon, James R. Kasinger, Lawrence Otto Klein, Michael John Tomsicek, Rodger Novak, Samarth Kulkarni, Tony W Ho. Learn more on insiders at CRSP.

What percentage of CRISPR Therapeutics stock is owned by insiders?

5.30% of CRISPR Therapeutics stock is owned by insiders. Learn more on CRSP's insider holdings.

Which CRISPR Therapeutics insiders have been selling company stock?

The following insiders have sold CRSP shares in the last 24 months: Bradley J Phd Bolzon ($6,551,006.38), Michael John Tomsicek ($3,463,000.00), Rodger Novak ($7,340,500.00), and Samarth Kulkarni ($16,941,430.00).

How much insider selling is happening at CRISPR Therapeutics?

Insiders have sold a total of 402,249 CRISPR Therapeutics shares in the last 24 months for a total of $37,402,716.38 sold.

This page (NASDAQ:CRSP) was last updated on 3/21/2023 by MarketBeat.com Staff